激光杂志
激光雜誌
격광잡지
LASER JOURNAL
2013年
6期
126-128
,共3页
缺血性脑卒中%前瞻性研究%门诊随访
缺血性腦卒中%前瞻性研究%門診隨訪
결혈성뇌졸중%전첨성연구%문진수방
ischemic stroke%prospective study%follow -up survey
提目的：通过调查及概述本院门诊缺血性卒中患者的医疗现状，评价神经科门诊缺血性卒中患者二级预防中期随访结果，Essen卒中风险评分量表（ESRS ）的有效性和可靠性及其与日常生活能力评定（mRS ）的相关性。方法：以2010．7至2010．9内新发脑梗死门诊随访患者为研究对象，调查患者基本情况、危险因素、合并用药情况，并进行Essen及mRS评分。1年后随访患者，评价心脑血管终点事件发生率及其与 Essen评分的关系。结果：入组102例患者，平均年龄67．4±岁，分别伴有糖尿病、高血压、高脂血症、动脉粥样硬化性疾病，追踪其一年后使用抗血小板药、降压药、降脂药及降糖药的比例。Essen评分与mRS评分呈正向相关关系；ESRS≥3分的患者终点事件发生率显著高于 ESRS＜3分的患者。结论：目前缺血性脑卒中的二级预防仍存在药物应用不足、慢性基础疾病控制率低、长期依从性较差等情况。Essen评分可以有效地评估患者发生终点事件的风险以及缺血性脑卒中患者的预后。
提目的：通過調查及概述本院門診缺血性卒中患者的醫療現狀，評價神經科門診缺血性卒中患者二級預防中期隨訪結果，Essen卒中風險評分量錶（ESRS ）的有效性和可靠性及其與日常生活能力評定（mRS ）的相關性。方法：以2010．7至2010．9內新髮腦梗死門診隨訪患者為研究對象，調查患者基本情況、危險因素、閤併用藥情況，併進行Essen及mRS評分。1年後隨訪患者，評價心腦血管終點事件髮生率及其與 Essen評分的關繫。結果：入組102例患者，平均年齡67．4±歲，分彆伴有糖尿病、高血壓、高脂血癥、動脈粥樣硬化性疾病，追蹤其一年後使用抗血小闆藥、降壓藥、降脂藥及降糖藥的比例。Essen評分與mRS評分呈正嚮相關關繫；ESRS≥3分的患者終點事件髮生率顯著高于 ESRS＜3分的患者。結論：目前缺血性腦卒中的二級預防仍存在藥物應用不足、慢性基礎疾病控製率低、長期依從性較差等情況。Essen評分可以有效地評估患者髮生終點事件的風險以及缺血性腦卒中患者的預後。
제목적：통과조사급개술본원문진결혈성졸중환자적의료현상，평개신경과문진결혈성졸중환자이급예방중기수방결과，Essen졸중풍험평분량표（ESRS ）적유효성화가고성급기여일상생활능력평정（mRS ）적상관성。방법：이2010．7지2010．9내신발뇌경사문진수방환자위연구대상，조사환자기본정황、위험인소、합병용약정황，병진행Essen급mRS평분。1년후수방환자，평개심뇌혈관종점사건발생솔급기여 Essen평분적관계。결과：입조102례환자，평균년령67．4±세，분별반유당뇨병、고혈압、고지혈증、동맥죽양경화성질병，추종기일년후사용항혈소판약、강압약、강지약급강당약적비례。Essen평분여mRS평분정정향상관관계；ESRS≥3분적환자종점사건발생솔현저고우 ESRS＜3분적환자。결론：목전결혈성뇌졸중적이급예방잉존재약물응용불족、만성기출질병공제솔저、장기의종성교차등정황。Essen평분가이유효지평고환자발생종점사건적풍험이급결혈성뇌졸중환자적예후。
Objective :To investigate the medical status of patients with ischemic stroke in outpatient department of our hospital and evaluate the middle -term follow -up results of secondary prevention ,validity and reliability of Essen score ,and the correlation between Essen score and mRS score of patients with ischemic stroke in neurology outpatient .Methods :During 2010 .7 2010 .9 ,the patients with new onset of cerebral infarction within half a year were enrolled to investigate the general information , risk factors and chronic drugs treatment , and to conducte Essen score and mRS score .The incidence of endpoint events including cebrocardiovascular endpoint events were evaluated and the relationship between endpoint events and Essen score were assessed after 1-year follow -up .Results :102 patients were enrolled with an average age of 67 .4 years .The patients complicated with diabetes ,hypertension ,hyperlipidemia ,and atherosclerosis disease accounted for 30 .4% ,70 .6% ,71 .6% ,49% ,respectively .The proportion of proper use of antiplatelet drugs ,antihypertensive drugs ,lipid -lowering drugs and hypoglycemic therapy were 82 .3% ,98 .6% ,76 .7% ,93 .5% ,respectively .The proportion of use of antiplatelet drugs ,antihypertensive drugs ,lipid -lowering drugs and hypoglycemic therapy were 74 .5% ,98 .6% ,63% ,87 .1% ,respectively after one -year follow -up .A positive correlation was proved between Essen score and mRS score .The incidence of endpoint events in patients with ESRS ≥ 3 was significantly higher than that with ESRS < 3 .Conclusion :The situations such as lack of drug application ,low rate of control of underlying chronic disease and poor long -term compliance still exist in the current secondary prevention for ischemic stroke .Also ,Essen score can be used as an effective tool for risk evaluatation of the incidence of endpoint events and one of referential criteria in patients with ischemic stroke .
